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Deng and Shuman (J. Biol Chem. 271, 29386 (1996)) reported that an ATPase different from the known viral termination
factor, VTF, is required for vaccinia virus early gene transcription termination. Properties of this ATPase were similar to those
of a known vaccinia virus enzyme, nucleoside triphosphate phosphohydrolase I (NPH I) the product of gene D11L.
Transcription-competent cell-free extracts were prepared from A549 cells infected with wild-type or mutant vaccinia virus
harboring ts mutations in gene D11L. These extracts were employed to investigate the role of NPH I in early gene
transcription termination. Extracts prepared under nonpermissive conditions from both wild-type virus and ts mutant
virus-infected cells exhibited high levels of early and intermediate gene transcription activity but were incapable of
supporting late gene transcription. ts mutant extracts lacked signal-dependent early gene transcription termination activity,
which was restored by the addition of either free NPH I or a GST-NPH I fusion protein. A comparison of the NPH I amino acid
sequence to the protein databases revealed the presence of a set of sequences characteristic of nucleic acid helicase
superfamily II members. A series of site-specific mutations in the helicase motifs and N-terminal and C-terminal deletion
mutations were expressed as GST fusion proteins and their activities assessed. Of the mutations in helicase motifs I to VI,
alteration of all but motif III reduced the ATPase activity. Removal of as few as 24 amino acids from the N-terminal end
eliminated ATPase activity, while deletion of 68 C-terminal amino acids exhibited only a modest decrease in ATP hydrolysis.
Larger C-terminal deletions eliminated ATPase activity. Each deletion mutation, and site-specific mutations other than the
motif III mutation, failed to support transcription termination in vitro. Mutations in motifs I, II, V, and VI inhibit wild-type NPH
I transcription termination activity. However, deletion of up to 68 amino acids from the C-terminal end eliminates this
inhibitory property. This observation is particularly interesting since these C-terminal deletions retain both ATPase activity
and single-stranded DNA binding activity. Their failure to inhibit transcription termination suggests that these C-terminal
deletion mutations eliminate a site required for a function other than from DNA binding or ATP hydrolysis. © 1998 Academic Press
INTRODUCTION
Double-stranded DNA containing poxviruses are
unique in that they replicate in the cytoplasm of infected
cells. In order to carry on this unusual life cycle,
poxviruses encode the enzymes required for viral gene
transcription, mRNA processing, and DNA replication
(Moss, 1996). Viral genes can be sorted into three
temporal classes. Early genes are transcribed in virus
cores. Intermediate and late genes are transcribed on
replicating DNA in the cytoplasmic replication factories.
Each class possesses its own unique set of class spe-
cific transcription initiation factors (Moss et al., 1991).
Due to properties shared with both prokaryotic and eu-
karyotic transcription machinery (Broyles and Moss,
1986; Amegadzie et al., 1992; Rosales et al., 1994) a de-
tailed investigation of poxvirus transcription promises to
yield valuable insights into transcriptional mechanisms
common throughout evolution.
Early viral genes are unique in that transcription ter-
minates in a signal- and factor-dependent manner (Rohr-
man et al., 1986; Yuen and Moss, 1986; Shuman et al.,
1987). Elongation proceeds beyond the sequence
TTTTTNT in the nontemplate strand yielding UUUUUNU
in the nascent mRNA which serves as a signal required
for the termination event (Yuen and Moss, 1987; Shuman
and Moss, 1989). Termination requires both the vaccinia
termination factor (VTF) and ATP or dATP hydrolysis
(Shuman et al., 1987; Hagler et al., 1994). VTF also serves
both as the viral mRNA capping enzyme (Shuman et al.,
1987) and as an essential intermediate gene transcrip-
tion initiation factor (Vos et al., 1991). Recent evidence
demonstrated that ATP hydrolysis required for termina-
tion is not catalyzed by VTF but rather by a different
enzyme, termed Factor X (Deng and Shuman, 1996).
Reconstitution experiments point to a nucleoside triphos-
phate phosphohydrolase activity with features similar to
NPH I, the product of gene D11L (Rodriguez et al., 1986;
Broyles and Moss, 1987b), as the ATPase employed in
transcription termination. During infection, transcription
termination is restricted to early genes. In vitro, only RNA
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polymerase capable of recognizing early promoters is
subject to signal-dependent termination, suggesting that
this form of RNA polymerase is uniquely termination
competent (Condit et al., 1996). Thus effective termina-
tion of early gene transcription requires the productive
interplay of at least four factors: the virion RNA polymer-
ase, the signal UUUUUNU in the nascent mRNA, VTF, a
multifunctional mRNA processing enzyme, and the ATP
hydrolyzing enzyme Factor X. A detailed investigation of
the mechanism of viral early gene transcription termina-
tion promises insights both into poxvirus gene expres-
sion and into termination mechanisms employed in cel-
lular systems.
A convenient scheme for analyzing viral transcription
in extracts of virus-infected cells was described (Condit
et al., 1996). By preparing extracts from cells infected at
the nonpermissive temperature with ts mutant virus, it
was possible to generate extracts devoid of a single
essential viral factor. Such null extracts are of general
use in evaluating functions of viral proteins in viral gene
expression in vitro. Three ts mutations, C50, C36, and
E17, were mapped to gene D11L (Seto et al., 1987). The
altered bases in C50 and C36 were identified (Kunzi and
Traktman, 1989; Kahn and Esteban, 1990). In this report,
we show that infected cell extracts can be prepared
lacking active vaccinia virus NPH I protein. Such extracts
are defective in early gene transcription termination. Ter-
mination activity can be restored by the addition of NPH
I expressed in and prepared from induced Escherichia
coli. Analysis of a limited set of in vitro generated muta-
tions demonstrates that NPH I ATPase activity is required
for termination. Furthermore, four sequences identified
as helicase superfamily II conserved regions (Gorba-
lenya and Koonin, 1993) are also essential both for AT-
Pase and transcription termination activity. Carboxyl ter-
minal deletion mutations which retain both ATPase and
DNA binding activity fail to terminate transcription in
vitro, demonstrating that this region of NPH I carries out
some essential function other than ATP hydrolysis. Fur-
thermore, these deletion mutations fail to serve as dom-
inant negative effectors in vitro, suggesting that this
region of NPH I interacts with some component involved
in the termination reaction. Our observations both con-
firm and extend the recent report by Deng and Shuman
(1998) in which they demonstrate a role for NPH I both in
early gene transcription elongation and in termination.
RESULTS
In vitro transcription
Sedimentation of virus-infected cells after treatment
with lysolecithin yields a transcription-competent cell-
free extract (Condit et al., 1996). Addition of plasmid DNA
containing a G-less cassette downstream from a viral
early, intermediate, or late gene promoter, along with
ribonucleoside triphosphates, permits synthesis of RNA,
which can be observed by gel electrophoresis. For a ts
mutation in gene D12L, preparation of extract from cells
infected at the nonpermissive temperature yielded ex-
tract deficient in both early gene transcription termina-
tion and intermediate gene transcription initiation activity
which could be restored by addition of VTF synthesized
in E. coli. This general approach provides a simple
means of preparing specific null extracts useful for stud-
ies on viral protein function in vitro.
With an initial goal of evaluating the role of NPH I in
early gene transcription termination, we sought to pre-
pare a transcription competent extract from cells in-
fected with ts virus altered in NPH I. To this end, three ts
virus that map in gene D11L were employed, C50, C36,
and E17 (Seto et al., 1987). Early gene transcription re-
quires late protein synthesis, while intermediate and late
gene transcription requires synthesis of early and inter-
mediate proteins, respectively. Since D11L ts mutations
exhibit a defective late phenotype (Condit et al., 1983),
which is reduced intermediate and late gene expression
at the nonpermissive temperature, extracts prepared
from cells infected at 40°C would be expected to exhibit
reduced early and late gene transcription. Since this was
shown to be true it became necessary to develop an
alternative approach to extract preparation. To permit the
accumulation of intermediate and late viral gene prod-
ucts required for early and late gene transcription, viral
infection was carried out initially at the permissive tem-
perature. After 24 h, the temperature was shifted to 40°C
with the hope of inactivating previously synthesized ts
NPH I, and cycloheximide was added to prevent further
protein accumulation. After an additional 24-h incuba-
tion, lysolecithin treatment was carried out and an in-
fected cell extract was prepared.
To assess overall transcription activity in such ex-
tracts, transcription was assayed employing plasmid
templates that possessed an early, intermediate, or late
gene promoter upstream from a G-less cassette. Specific
transcription of each plasmid yields a 380-nucleotide
product. As a control, an extract was prepared from cells
infected with wild-type virus at 40°C, as described by
Condit et al. (1996). Alternatively, extracts were prepared
from cells initially infected at 31°C, either with wild-type
virus or with ts C50, and after 24 h shifted to 40°C and
incubated for a further 24 h in the presence of cyclohex-
imide. The wild-type virus-infected cell extract exhibits
the expected levels of early, intermediate, and late gene
transcription (Fig. 1). Extracts prepared from either wild-
type or C50 virus-infected cells, experiencing further in-
cubation in the presence of cycloheximide, yielded re-
duced but satisfactory levels of early and intermediate
gene transcription. The reduced activity may reflect dif-
ferences in length of incubation at 40°C or simply vari-
ability in extract preparation. However, late gene tran-
scription activity is absent in the cycloheximide-treated
infected cell extract. This observation suggests that one
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or more late transcription factors is unusually labile and
unable to withstand the prolonged incubation at 40°C in
cycloheximide. E17-infected cell extracts exhibited a
similar level of total transcription, but C36-infected cell
extracts lacked significant transcription activity and were
not studied further. Additional investigations of possible
variables in extract preparation were not conducted.
Western blot analysis was employed to assess the
amount of NPH I in the wild-type and ts mutant virus C50-
and E17-infected cell extracts, prepared from cells in-
fected at 40°C and treated with cycloheximide. Different
volumes of each extract were separated by gel electro-
phoresis, transferred to nitrocellulose, and probed with
antibodies directed against either NPH I or the small
subunit of the viral mRNA capping enzyme, D12L. This
latter subunit serves as a control since the D12L subunit
is known to be stable during infection (Niles et al., 1989).
In Fig. 2. it can be seen that the level of NPH I in the
C50-infected cell extract is reduced in comparison to the
wild-type virus-infected cell extract. However, the level of
NPH I found in the E17-infected cell extract is barely
detectable, indicating that the E17 NPH I is particularly
unstable. It is not uncommon to find that vaccinia virus ts
mutations exhibit reduced protein stability (Dyster and
Niles, 1991). Since the extract prepared from C36-in-
fected cells exhibited low transcription activity, it was not
evaluated further. However, based on other observations
(Diaz-Guerra and Esteban, 1993), one would expect that
the ts C36 NPH I would be stable under these conditions.
To evaluate the ability of wild-type or ts mutant virus-
infected cell extracts to support early gene transcription
termination we next employed a supercoiled plasmid
template, pSBterm, that possesses a G-less cassette
harboring tandem termination signals downstream from
an early viral promoter (Condit et al., 1996). Read through
transcription yields a 540-nucleotide product and signal-
dependent termination produces a 450-base transcript.
Extracts prepared from cells infected with ts C50 at 40°C
were compared to wild-type virus-infected cells (Fig. 3).
In the case of wild-type virus-infected cell extracts, ex-
tract alone exhibited mostly read through transcript with
a low level of termination product. Addition of VTF alone
enhances the production of the terminated transcript.
The addition of NPH I alone had no effect on total RNA
synthesis or on transcription termination in the wild-type
virus-infected cell extract, in the presence or the ab-
sence of VTF. Transcription employing ts C50-infected
cell extract alone yields only the read through product.
Addition of VTF alone, however, does not enhance tran-
scription termination, in contrast to the wild-type virus-
infected cell extract. Addition of NPH I alone supports a
small increase in termination but since VTF is limiting
little termination product is observed. However, addition
of both VTF and NPH I restores transcription termination,
demonstrating that both proteins are essential termina-
tion cofactors. Both free NPH I and GST-NPH I exhibit
similar activity in this assay, demonstrating that the N-
terminal GST domain does not affect NPH I function (data
not shown).
Helicase signature motifs in NPH I
A comparison of the NPH I amino acid sequence to the
protein data bases identifies a series of proteins that
FIG. 2. Western blot analysis of virus-infected cell extracts. A549
cells were infected with wild-type virus or with ts mutants C50 or E17,
at an m.o.i. of 15, at 31°C. After incubation for 24 h, the temperature was
raised to 40°C and cycloheximide was added to 100 mg/ml. Infected
cell extracts were prepared after incubation for an additional 24 h.
Different volumes of extract were denatured, separated by gel electro-
phoresis, transferred to nitrocellulose, and treated with either anti-D11L
or anti-D12L polyclonal antiserum. The positions of the bound antibod-
ies were determined by alkaline phosphatase-linked second antibody.
FIG. 1. Transcription activity of virus-infected cell extracts. A549 cells
were infected with wild-type virus at either 31° or 40°C or with ts
mutant C50 at 31°C, at an m.o.i. of 15. For the 40°C wild-type virus-
infected cell sample, a cell extract was prepared after incubation for
24 h (WT). After incubation of the wild-type or C50 ts mutant virus-
infected cell cultures for 24 h at 31°C, the temperature was raised to
40°C and 100 mg/ml cycloheximide was added. Extracts were prepared
after incubation for an additional 24 h at 40°C (WTc, C50). Transcription
activity was measured at different extract concentrations using super-
coiled plasmid templates that possessed a strong synthetic early
promoter (Early), the gene G8R intermediate promoter (Inter), or late
viral gene F17R promoter (Late), driving transcription through a 380-bp
G-less cassette. Specific transcription of each template yields a 380-
nucleotide RNA product that is visualized after electrophoresis in a 5%
acrylamide, 8 M urea gel. The protein concentrations in each extract
were WT, 1.2 mg/ml; WTc, 1.0 mg/ml; C50, 0.7 mg/ml.
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exhibit significant sequence homology to NPH I. Promi-
nent among these proteins are several known to belong
to the helicase superfamily II (Gorbaleyna and Koonin,
1993). Seven degenerate sequence motifs have been
associated with superfamily II helicases. Each motif con-
tains a sequence consisting of highly conserved amino
acids in addition to structurally homologous amino acids.
NPH I possesses five perfect matches (Fig. 4). Possible
candidates for the two remaining motifs can be found
which possess one or two amino acid alterations. Of the
motifs present in NPH I, two coincide with the Walker A
and B box sequences (Walker et al., 1982), proposed to
be associated with ATP binding. To date, helicase activity
has been demonstrated in only a small fraction of pro-
teins identified as helicase superfamily members. Al-
though the presence of helicase sequence motifs in NPH
I does not demonstrate function, it is pleasing to spec-
ulate that NPH I might serve as a helicase in the termi-
nation process.
Initial mutagenic analysis of NPH I function
A set of N-terminal and C-terminal deletion mutations
in NPH I were constructed in addition to site-specific
mutations in five of the superfamily II helicase motifs
(Table I). Each mutation was expressed as a GST-NPH I
fusion protein and isolated from induced E. coli. For each
mutant fusion protein, a prominent degradation product
copurifies with the full-length product (Fig. 5). Since the
60-kDa truncated fusion proteins bind to glutathione
Sepharose, each must be deleted at the carboxyl termi-
FIG. 3. Transcription termination activity of wild-type virus and ts
mutant virus-infected cell extracts. Extracts of virus-infected cells were
prepared as described in Fig. 2. A supercoiled plasmid template,
pSBterm (Condit et al., 1996), containing a G-less cassette harboring
tandem termination signals downstream from a viral early promoter
was employed. Read through transcripts synthesized in the presence
of UTP, CTP, ATP, and 39 O methyl GTP are 540 bases in length. Signal
specific transcription termination yields a 450-base RNA product. The
D11L protein (NPH I) was released from the GST-D11L fusion protein by
thrombin treatment and separated from GST by passage through a
glutathione Sepharose column. VTF (viral mRNA capping enzyme) was
prepared from E. coli engineered to express both subunits (Higman et
al., 1992). RT, read through transcript; T, termination product.
FIG. 4. NPH I possesses sequence motifs present in superfamily II
helicases. Comparison of the NPH I amino acid sequence to the data
bases reveals striking conservation of several motifs present in super-
family II helicases (Gorbaleyna and Koonin, 1993). The relative posi-
tions of seven putative motifs are denoted as boxes along an arrow
which symbolizes the 631-amino-acid protein sequence. NPH I se-
quences corresponding to motifs I, II, III, V, and VI are written below
each box. Five of the seven sequence motifs in NPH I contain both
highly conserved amino acids (capital letters) and structurally homol-
ogous hydrophobic or hydrophilic amino acids (small letters). The five
motif sequences exhibit a perfect match with the proposed consensus
sequences. Motifs I and II correspond to the Walker A and B boxes
(Walker et al., 1982). Also noted are the positions of two ts mutations,
C50 and C36.
TABLE 1
NTP I ATPase Activity (nmol/min/mg)
Enzyme Amino acids
Experiment
1 2
Wild type 1–631 30.1 41.6
59 D1 25–631 0.09
59 D5 185–631 0
59 D6 225–631 0
39 D1 1–603 3.9 13.4
39 D2 1–563 25 20.3
39 D3 1–524 0.22 0.05
39 D4 1–483 0.02 0.02
39 D5 1–433 0.01 0.02
Motif
m1 GVGKT I 0 0
m2 DECH II 0.21 0.09
m3 SATPI III 36.9 46.7
m4 GGEG V 0.39 0.84
m5 RAIR VI 0.02 0.05
Note. ATPase activity measurements were carried out at different
concentrations of wild-type or mutant GST-D11L at 10 mM ATP, 10 mM
MgCl2 (experiment 1) or 1 mM ATP, 1 mM MgCl2 (experiment 2).
Phosphate release was measured after incubation with enzyme for 10
min and phosphate concentration was calculated from a standard
phosphate curve. The observed rate was plotted at different enzyme
concentrations and the specific activity was calculated from the slope
of the straight line and is presented as nmol/min/mg enzyme. The
wild-type amino acid sequence for each helicase homology motif is
presented for single site mutants m1 to m5. The mutations are as
follows: m1, K61D; m2, E142K; m3, T185A, P186A; m4, G446R; m5,
R476S, R479A.
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nal end. As will be seen, such carboxyl terminal dele-
tions lack both ATPase and single-stranded DNA binding
activity and are unable to support transcription termina-
tion. Therefore, these truncated fusion proteins would be
expected to have little effect on the set of analyses
presented in this report. Passage of the protein over
phosphocellulose at pH 6.8 increases purity of the GST-
NPH I fusion protein. Although impure, each protein
preparation was devoid of deoxyribonuclease and phos-
phatase activity. Some preparations had measurable ri-
bonuclease activity but in all cases, the level of ribonu-
clease did not prevent their use.
Nucleoside triphosphate phosphohydrolase activity
ATPase activity was measured for both wild-type GST-
NPH I and each mutant form. Measurements were con-
ducted at either 1 mM ATP and MgCl2 or 10 mM ATP and
MgCl2 and at saturating single-stranded DNA concentra-
tions. ATPase activity was shown to be linear with re-
spect to time and enzyme concentration (data not
shown). Free NPH I exhibits the same specific activity as
the GST fusion protein, demonstrating that the GST do-
main does not interfere with substrate or activator bind-
ing or with catalysis. For site-specific mutations in the
helicase superfamily II motifs, alteration of motifs I, II, V,
and VI severely reduced catalytic activity (Table 1). Motifs
I and II correspond to the Walker A and B boxes (Walker
et al., 1982) and a significant reduction in ATPase activity
would be expected. Based on this observation, a function
for motifs V and VI in either ATP binding or catalysis
would be anticipated. A double amino acid substitution
in motif III, common to all superfamily II helicases, failed
to affect ATPase activity, however. Deletion of as few as
24 N-terminal amino acids eliminated ATPase activity. If
the putative Walker A and B boxes are employed in ATP
binding, this would be expected. ts mutation C50 maps in
the same area of NPH I (Fig. 4), but its effect on ATPase
activity has not been measured (Kunzi and Traktman,
1989; Kahn and Esteban, 1990). Larger N-terminal dele-
tions remove the putative Walker A and B boxes and lack
ATPase activity, as well. Deletion of 68 amino acids from
the C-terminus has little effect on ATPase activity; how-
ever, removal of an additional 39 amino acids reduces
the ATPase activity more than 100-fold.
Transcription termination activity
The ability of each NPH I mutation to support tran-
scription termination in C50-infected cell extracts was
next assessed. Of the single site mutations, m1 to m5,
only m3 permitted transcription termination (Fig. 6). This
mutation possesses two amino acid alterations yet it
retains full activity. Although highly conserved, this motif
is not required for NPH I activity in vitro, either as an
ATPase or as a termination cofactor. Among m1 to m5
mutations, the loss of ATPase activity correlates well with
the loss of transcription termination activity. Each N-
terminal deletion mutant lacks the ability to stimulate
termination in vitro, in agreement with their loss of
ATPase activity (Table 1). For the C-terminal deletion
mutations, none retain the ability to support transcription
termination, in spite of the fact that deletion of up to 68
amino acids permits retention of high levels of ATPase
activity. Since the 39 D1 and 39 D2 mutations retain
ATPase activity they are also likely to retain ssDNA
binding. These observations suggest that the C-terminal
region of NPH I may play a role in termination other than
ATP hydrolysis.
Single-stranded DNA binding by wild-type
and mutant NPH I
Single-stranded DNA binding by NPH I can be quan-
tified by an electrophoretic mobility shift assay (Figs.
7A–7D). Binding yields two shifted complexes at each
protein concentration tested for either free NPH I (Fig.
7B) or for the GST-D11L fusion protein derivatives (Fig.
FIG. 5. Gel electrophoretic analysis of wild-type and mutant GST-D11L fusion proteins. Wild-type and mutant GST-D11L fusion proteins were purified
from induced E. coli possessing pGEX 4T1-D11L plasmid derivatives. An S100 fraction was prepared from induced cells and passed sequentially over
glutathione Sepharose and heparin agarose. Protein samples were denatured, separated in a 10% polyacrylamide gel, and stained with Coomassie
blue. For the wild-type fusion protein, greater than 90% purity was routinely obtained. For the mutant fusion proteins, the level of purity varied from
about 40 to 80%. The prominent contaminant in each case is a 60-kDa truncated fusion protein. Other minor bands also are derived from the full-length
fusion protein.
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7C). This behavior is consistent with the protein/DNA
complex adopting two conformations. Both free NPH I
and GST-D11L fusion protein exhibit equivalent affinity,
demonstrating that the GST domain does not interfere
with ssDNA binding. Binding is also dependent upon the
length of the single-stranded DNA probe, with shorter
DNA exhibiting weaker binding (data not shown). The
DNA binding ability of the collection of GST-NPH I mu-
tations was assessed using ssDNA24 and similar con-
centrations of total GST-NPH I (Fig. 7A). Single site mu-
tations, m2 to m5, bind as well as the wild-type GST-D11L
protein. However, the m1 mutation exhibits significantly
weaker binding. N-terminal deletion 59 D1 displays sub-
stantially reduced binding, while 59 D5 lacks measurable
DNA binding activity. C-terminal deletion mutations 39 D1
and 39 D2 also exhibit high DNA binding. However, bind-
ing by larger carboxyl terminal mutations 39 D3 and 39 D4
is dramatically reduced and the longest mutation 39 D5
lacks any binding activity. The reduction of ATPase ac-
tivity observed in deletion mutants 39 D3 to 39 D5 might
be a result of altered DNA binding rather than a direct
effect on the ATPase active site. It is interesting to note
that mutations 39 D1 and 39 D2 retain both ATPase
activity and single-stranded DNA binding yet fail to sup-
port transcription termination.
Ability of NPH I mutants to act as dominant negative
inhibitors of transcription termination in vitro
Altered forms of GST-D11L were analyzed in a com-
petition experiment to assess whether the GST-D11L
mutants possess the ability to inhibit transcription termi-
nation in vitro. Electrophoretic analysis of product RNA
showed that mutant m2 inhibited transcription termina-
tion in a concentration-dependent fashion (Fig. 8A). Sim-
ilar results were obtained for m1, m4, and m5 (data not
shown). These results suggest that the site-specific mu-
tations compete with the wild-type GST-D11L protein for
binding to some essential termination component. N-
terminal and C-terminal deletion mutations fail to inhibit
FIG. 6. Transcription termination activity of wild-type and mutant GST-D11L proteins in vitro. An extract prepared from ts C50-infected cells was
employed in each reaction. Transcription was carried out in the presence or the absence of the indicated amounts of VTF and wild-type or mutant
GST-D11L. RNA was isolated, separated by gel electrophoresis, and located by phosphorimaging. RT, 540-base read through product; T, 450-base
terminated transcript.
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termination, however, indicating that they are unable to
compete. Of particular interest are 39 D1 and 39 D2,
which retain normal ssDNA binding and ATPase activity
yet fail to support termination in vitro. The decrease in
overall RNA synthesis observed at high GST-D11L is due
to a low level of contaminating RNase. Since these mu-
tations also fail to act as dominant negative effectors of
termination it suggests that the carboxyl terminal end of
NPH I interacts with one or more other components of
the termination system.
N-terminal deletions also fail to act as inhibitors,
which may indicate that this region of NPH I may also be
important in such interactions. However, N-terminal mu-
tations lack both ATPase activity and ssDNA binding. As
a result, we have no means of assessing proper folding
for these mutant protein. Therefore, we cannot be certain
that their failure to inhibit isn’t due simply to improper
folding during synthesis.
DISCUSSION
Extracts can be prepared from lysolecithin-treated
vaccinia virus-infected cells and employed in the analy-
sis of viral gene transcription (Condit et al. 1996). For a ts
mutation in the viral early gene D12L, a null extract
lacking D12L was generated and proved useful in dem-
onstrating that this protein is required for intermediate
gene transcription initiation. In order to evaluate the role
of NPH I in viral early gene transcription termination a
similar approach was undertaken. However, since ts
mutations in gene D11L exhibit reduced intermediate
and late gene transcription (Kunzi and Traktman, 1989)
and the two subunits of VETF, the viral early gene tran-
scription initiation factor, and virion RNA polymerase
subunits are synthesized late in infection, an alternate
approach was undertaken. By initially infecting at the
permissive temperature, normal viral protein synthesis
takes place and late gene products accumulate in the
FIG. 8. Inhibition of transcription termination by mutant forms of
GST-D11L. Transcription reactions were carried out employing an ex-
tract derived from ts C50 virus-infected cells including 5 pmol of VTF,
0.05 pmol of wild-type GST-D11L, and the indicated level of mutant
GST-D11L (pmol). (A–C) Titration of the m2 mutation of GST-D11L, the 39
D2 mutation of GST-D11L, and the 59 D5 mutation of GST-D11L, respec-
tively. Motif mutations m1, m4, and m5 exhibit inhibitory activity indis-
tinguishable from that of m2. M, molecular weight markers.
FIG. 7. EMSA analysis of wild-type and mutant GST-D11L proteins.
(A) Incubations were set up on ice containing 10 fmol of 59 end-labeled
ssDNA24 and 2 mg of wild-type or mutant GST-D11L (1 mg, approxi-
mately 10 pmol). Samples were separated in a 6-cm polyacrylamide
gel, at 4°C, and after drying the gel, the positions of the 32P-labeled
ssDNA24 were determined by phosphorimage analysis. (B–D) Titration
of free NPH I, wild-type GST-D11L, and the 39 D2 deletion mutation,
respectively.
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infected cell. After shifting to the nonpermissive temper-
ature, the ts mutant proteins are inactivated. Addition of
cycloheximide inhibits further viral protein synthesis. If
the normal viral proteins are stable at this temperature
and the ts mutant protein is unstable, a null extract can
be prepared. Analysis of total transcription activity
showed that early and intermediate gene transcription is
retained in these extracts but late gene transcription
activity is lost. This observation suggests that one or
more late gene transcription factors is unstable and
inactivated by the extended incubation at 40°C. Although
reduced early and intermediate gene transcription activ-
ity was observed in these extracts, they were shown to
lack early gene transcription termination activity and
proved to be useful for these studies. Western blot anal-
ysis demonstrated that the NPH I protein was retained in
C50-infected cell extracts, albeit at a reduced level. In
extracts prepared from E17-infected cells, little NPH I
protein was found. Degradation of vaccinia virus ts mu-
tant proteins is commonly observed (Dyster and Niles,
1991).
Analysis of transcription termination activity in vitro
demonstrated that the ts mutant virus-infected cell ex-
tracts failed to terminate. Addition of VTF did not restore
termination activity to the ts mutant virus-infected cell
extracts, unlike extracts prepared from wild-type virus-
infected cells. However, addition of either GST-D11L or
free NPH I, in addition to VTF, restored termination ac-
tivity, providing strong evidence that NPH I is an essen-
tial termination cofactor. This conclusion is supported by
the observation that NPH I mutants lacking ATPase ac-
tivity also fail to terminate in vitro and is in agreement
with the results of Deng and Shuman, (1998).
A comparison of the NPH I amino acid sequence to the
databases reveals a strong structural homology to the
superfamily II helicases (Gorbalenya and Koonin, 1993).
NPH I possesses five of the seven signature motifs with
less-well-conserved matches to the other two. A series
of N-terminal and C-terminal deletion mutations and sev-
eral site-specific mutations were constructed and ex-
pressed as GST fusion proteins. Analysis of their ATPase
activities demonstrated that the mutations altered in the
helicase superfamily II motifs I, II, V, and VI lacked ac-
tivity. A double mutation in motif III, however, retained
activity in vitro, indicating that this sequence is not es-
sential for ATP hydrolysis. Motifs I and II correspond to
the well-known Walker box A and B sequences (Walker
et al., 1982), which are expected to be involved in ATP
binding. It is not surprising that ATP hydrolytic activity
would be lost in these mutations. The functions of motifs
V and VI are not well known and their role in ATP
hydrolysis should be investigated further. The shortest
N-terminal deletion impinges upon motifs I and II and
almost certainly would effect ATP binding. ts mutation
C50, G44E, maps just to the left of the putative Walker A
box which begins at amino acid G58, GVGKT. Altered
ATPase activity would be anticipated in the C50 NPH I.
The shortest C-terminal deletion mutations retain
ATPase activity. In deletion 39 D1, ATPase activity is
somewhat variable, up to 30% of the wild-type enzyme in
some preparations. 39 D2 is consistently 60% or so of the
normal ATPase activity. These results demonstrate that
the C-terminal region is not essential for ATPase activity.
Furthermore, since ATPase activity requires single-
stranded DNA binding (Paoletti et al., 1974), removal of
the C-terminal 68 amino acids must not alter DNA bind-
ing. Larger C-terminal deletions, however, eliminate ATP
hydrolytic activity.
Each single site mutation except m3, a double substi-
tution in motif III, fails to support transcription termination
in vitro. For the mutations that lack ATPase activity, this is
not surprising and supports the notion that NPH I pro-
vides the ATPase activity employed in transcription ter-
mination. The m3, motif III, mutation is particularly inter-
esting in that it retains both ATPase and transcription
termination activity. However, in ts C36, Pro 186 is
changed to Ser (Kahn and Esteban, 1990), indicating that
this region of NPH I plays an essential role in vivo.
Further biochemical analysis of C36 is required to define
the biochemical basis of the ts mutation. A three-amino-
acid substitution in the equivalent sequence in eIF-4A
also retains ATPase activity yet lacks RNA unwinding
activity in this well-known helicase (Pause and Sonen-
berg, 1992). A family of mutations in the herpes virus UL9
motif III sequence lack the ability to complement loss of
function in vivo, indicating that this motif is essential for
UL9 function (Martinez et al., 1992). Both observations
support an essential role for motif III in eIF4A and UL9
activity. Either motif III in NPH I is indeed nonessential for
termination or our in vitro assay does not accurately
reproduce its in vivo requirement. Analysis of additional
motif III mutations will be conducted in order to resolve
this issue.
Motif VI corresponds to a similar sequence in the
vaccinia virus NPH II RNA helicase. Mutations in the
NPH II sequences reduce both ATP hydrolysis and RNA
unwinding without significantly reducing RNA binding
(Gross and Shuman, 1996). These observations contrast
with those reported by Pause and Sonenberg (1992) in
which they attributed their loss of ATPase activity in a
similar set of eIF4A mutations to reduced RNA binding.
Differences in results obtained for mutant forms of vari-
ous helicases may be a reflection on their varied subunit
composition and biological functions. In regard to a pu-
tative helicase function for NPH I, although correlative,
results from other systems have little direct bearing and
only a successful demonstration of unwinding activity in
vitro will permit defining this protein as a helicase. To
date, attempts to demonstrate helicase activity in pure
GST-D11L employing simple RNA/DNA helicase sub-
strates have failed (Friedman and Niles, not shown).
Perhaps one or more additional factors are required for
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unwinding activity. Mutations in the NPH I helicase mo-
tifs II to VI exhibit normal single-stranded DNA binding in
our analyses. However, a single substitution in motif I
reduces DNA binding. The cause of this reduction is not
obvious but is consistent with the reduction of DNA
binding observed for the N-terminal deletion mutations.
Carboxyl terminal deletions 39 D1 and 39 D2 exhibit an
interesting property. Each of these deletion mutations
retains both ATPase activity and the ability to bind single-
stranded DNA. However, each mutation lacks transcrip-
tion termination activity. These observations suggest that
the C-terminal region of NPH I is employed in some
function other that ATP hydrolysis and DNA binding.
Furthermore, neither deletion mutation is capable of act-
ing as a competitive inhibitor of GST-D11L in an in vitro
transcription termination assay. One simple model pro-
poses that the C-terminal region of NPH I binds to some
additional factor required for termination. Loss of the
C-terminal 68 amino acids eliminates binding, which not
only prevents termination but also prevents competition
with wild-type GST-D11L. This putative NPH I binding
partner could be VTF, a subunit of the virion RNA poly-
merase, or perhaps some as yet unidentified essential
termination factor. Prior results support a direct interac-
tion between NPH I and the virion RNA polymerase
(Broyles and Moss, 1987a; Zhang et al., 1994). Recent
evidence demonstrates the presence of NPH I in a
paused ternary complex (Deng and Shuman, 1998). N-
terminal mutations also fail to inhibit GST-D11L in vitro.
Unfortunately, due to the lack of any measurable activity,
one cannot be certain that these deletion mutations
folded properly. As a result, it is premature to propose an
interaction between the N-terminal region and one or
more partners at this time.
Any model attempting to explain poxvirus early gene
transcription termination must take into account the fol-
lowing facts (Fig. 9). Termination requires the sequence
UUUUUNU in the nascent mRNA (Rohrman et al., 1986;
Yuen and Moss, 1987; Shuman and Moss, 1989). The
UUUUUNU containing mRNA must be tethered to the
transcription complex yet UUUUUNU must be free, pre-
sumably to be available for interaction with some other
component (Deng et al., 1996). In addition, termination
requires VTF, the viral multifunctional mRNA processing
enzyme consisting of the products of genes D1R and
D12L (Shuman et al., 1987). The role of VTF is undefined
but the enzyme is clearly capable of productive RNA
binding. However, a strong preference for the sequence
UUUUUNU has not been demonstrated to date (Luo and
Shuman, 1993; Higman et al., 1994). Termination is lim-
ited to the RNA polymerase that is capable of initiation at
early gene promoters (Condit et al., 1996). Although a
specific interaction with the H4L subunit, unique to the
virion RNA polymerase (Ahn and Moss, 1992), would be
an attractive mechanism for restriction of termination to
early genes, recent evidence argues against this model
(Deng and Shuman, 1996). Finally, ATP hydrolysis by
NPH I is required. Since NPH I must bind single-stranded
DNA to stimulate ATPase activity, this requirement ar-
gues strongly that NPH I must be able to interact with
single-stranded DNA during the termination reaction.
Since the template strand is bound to nascent mRNA in
the transcription bubble, the most likely source of single-
stranded DNA is the free nontemplate strand, in the
paused ternary complex. This fact supports a model in
which the DNA binding site on NPH I interacts with the
nontemplate strand, activating a cryptic ATPase active
site. Furthermore, the inability of C-terminal deletion mu-
tations to serve as dominant negative effectors of termi-
nation in vitro argues strongly that a productive interac-
tion of the C-terminal region of NPH I with some com-
ponent of the termination system is essential. Further
genetic and biochemical investigations of the interplay
among these termination cofactors promises to resolve
the current ambiguities.
MATERIALS AND METHODS
Cells and virus
Wild-type vaccinia virus WR and ts mutant viruses C50,
C36, and E17 (Condit and Motyczka, 1981; Condit et al.,
1983; Ensinger, 1982) were propagated on BSC40 African
green monkey cells, at the permissive temperature,
31°C, as described (Condit and Motyczka, 1981). Crude
virus containing extracts of infected cells were prepared
by freeze/thaw, and infectious virus titers were deter-
mined on BSC40 cells at the permissive temperature,
31°C, and the nonpermissive temperature, 40°C.
FIG. 9. A cartoon depicting a model of the vaccinia virus early gene
transcription termination complex. Any mechanism considered for ter-
mination of early gene transcription must include the following obser-
vations. Termination requires the presence of the sequence UUUUUNU
in the nascent mRNA. VTF, the viral mRNA capping enzyme, is an
essential factor whose role in termination is undefined. Only RNA
polymerase that recognizes early promoters is sensitive to signal-
dependent termination. This form of virion RNA polymerase possesses
the H4L subunit. Finally, a single-stranded DNA-dependent ATPase
activity, NPH I, with helicase homology motifs, is employed as an
energy transducing factor.
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Transcription
Extracts of virus-infected cells were prepared by lyso-
lecithin treatment, as described (Condit et al., 1996).
A549 cells were infected with wild-type virus or ts mu-
tants C50, C36, and E17, at a multiplicity of infection
(m.o.i.) of 15, at the permissive temperature, 31°C. After
24 h, the medium was removed and replaced with 40°C
medium containing 100 mg/ml of cycloheximide. After a
further 24 h, cells were washed and treated with 250
mg/ml lysolecithin and extracts prepared. Transcription
assays were carried out in 10 ml total volume containing
1 to 6 ml extract, 1 mM ATP, 1 mM UTP, 20 mM CTP, 2 mCi
[a-32P]CTP, 0.2 mg supercoiled plasmid DNA, 25 mM
HEPES buffer, pH 7.4, 50 mM KCH3COO, 5 mM MgCl2, 1
mM dithiolthreitol, and 7.5% glycerol for 30 min at 30°C.
Total early, intermediate, or late gene transcription activ-
ity was measured employing templates containing a
strong artificial early promoter, an intermediate promoter
derived from the G8R gene, or the late F17R gene, as
described previously (Condit et al., 1996). Termination of
early gene transcription was monitored by using a plas-
mid template, pSBterm, which possess tandem termina-
tion signals within the G-less cassette. After proteinase K
treatment, RNA was isolated by extraction with phenol/
chloroform, precipitated with isopropanol, and resus-
pended in formamide. After heating at 90°C, samples
were separated by electrophoresis in 5% acrylamide 8 M
urea gels and the RNA were visualized by phosphorim-
age analysis or by autoradiography. Termination effi-
ciency was calculated as the molar ratio of terminated
RNA to the sum of read through and terminated RNA.
Expression and purification of GST-D11L
The entire coding region of gene D11L was amplified by
PCR. The 59 primer possessed a BglII site upstream from
the translation initiation ATG and the 39 primer included a
single SalI site. The PCR product was inserted into the
SmaI site of pGEM 3 Zf1, yielding pGEM 3 Zf1-D11L, and
the sequence of the D11L gene was determined to assess
fidelity of amplification. The BglII to SalI region was inserted
in frame into pGEX 4T1 cut with BamHI and SalI and
transformed into E. coli TB-1. Induction of mid-log phase
cells yielded the synthesis of a 98-kDa GST-NPH I fusion
protein. Large-scale induction was carried out at 20°C as
described (Higman et al., 1992). Cells were collected by
centrifugation and stored at 270°C until used. The first
several steps of purification, through the S100 step, were
described for the mRNA capping enzyme (Higman et al.,
1992). GST-NPH I was purified from an S100 fraction of
induced cells by sequential affinity chromatography on glu-
tathione Sepharose and heparin agarose. NPH I was eluted
from the heparin agarose column with a linear gradient
from 0 to 0.5 M NaCl. In some instances, GST-NPH I was
cleaved with thrombin and NPH I was separated from free
GST by chromatography on glutathione Sepharose.
Mutagenesis
Both deletion mutations and site-specific mutations
were constructed in the NPH I coding sequence. The 59
and 39 deletions were constructed by PCR employing
primers that were complementary to various positions in
the NPH I coding sequence. For the 59 deletions, the 59
primers were synthesized so that a single BglII site was
incorporated upstream from the first NPH I codon such
that the insertion of the NPH I sequence into the BamHI
site in pGEX 4T1 would generate a coding sequence in
which the NPH I sequence would be in frame with the
GST sequence. For 39 deletions, the 39 primers contained
tandem translation termination signals adjacent to the
final NPH I codon. Site-specific mutagenesis of D11L
was conducted by the Kunkel method using the dut/ung
system (Kunkel et al., 1987) purchased in kit form from
Bio-Rad. The D11L sequence in pGEM 3Zf1-D11L was
isolated as a single strand containing dUMP. Selected
mutagenic primers were annealed and elongated and
the double-stranded plasmids were transformed into E.
coli TB-1. Plasmids were isolated from progeny colonies
and the sequence of the D11L gene in the region of each
mutation was determined. pGEX 4T1 2D11L plasmids
containing mutant sequences were constructed by ex-
change of specific DNA fragments between pGEX 4T1-
D11L and mutant pGEM 3Zf1-D11L. Mutant GST-D11L
fusions were isolated from induced E. coli as described
for the wild-type fusion protein. In some instances further
purification on phosphocellulose at pH 6.8 was included.
Immunological techniques
A trp E fusion plasmid (Dieckmann and Tzagoloff, 1985)
was constructed capable of expressing a fusion protein
containing the D11L coding sequence from amino acids
142 to 631 linked to the trp E protein, by insertion of a
portion of the vaccinia virus HindIII D fragment from a BglII
site at 10,822 to a BamHI site at 12,838 (Niles et al., 1986).
Induction of E. coli TB-1 containing this plasmid yielded a
fusion protein that was purified from inclusion bodies by
preparative acrylamide gel electrophoresis and employed
in the generation of a rabbit polyclonal antiserum contain-
ing antibodies directed against the D11L protein. Western
blots were conducted as described (Niles and Seto, 1988)
using either anti-D11L or anti-D12L antibodies. Anti-D12L
antibodies are directed against the small subunit of the
mRNA capping enzyme and serve as a control (Niles et al.,
1989).
Nucleoside triphosphatase (ATPase) assay
The release of inorganic phosphate from ATP was
quantified by the colorimetric assay as described by
Myette and Niles (1996). Standard reactions were carried
out in a 100-ml total volume, for 10 min at 37°C, contain-
ing 100 mM MES, pH 7.0, 1 mM ATP, 1 mM MgCl2, 5 mM
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dithiolthreitol, and 5 mg heat-denatured calf thymus DNA
(Paoletti et al., 1974). Wild-type or mutant GST-D11L or
free NPH I concentrations ranged up to 0.3mg per assay.
For time course determination, 500-ml reactions were
prepared. At times after enzyme addition, 100-ml aliquots
were removed and quenched with 2.5 ml 250 mM EDTA
and free phosphate was determined. GST-NPH I and free
NPH I exhibited similar specific activities in this assay.
Mobility shift analysis
Single-stranded DNA (ssDNA) mobility shift analyses
were conducted as described (Higman et al., 1994). Re-
actions (20 ml) were prepared on ice containing 50 mM
Tris HCl, pH 8.0, 10% glycerol, 10 mM b-mercaptoethanol,
10 fmol of 59-labeled ssDNA24, a 24-nucleotide DNA
fragment whose sequence corresponds to the top strand
of the pGEM3Zf1 polylinker from nucleotides 5 to 28, and
up to 5 mg protein. One microgram of GST-D11L is ap-
proximately 10 pmol of protein. Electrophoresis was con-
ducted at 4°C in gels that were 1.5 mm thick and 6 cm
long, for 45 min at 200 V. The migration position of the
ssDNA was observed either by phosphorimage analysis
or by autoradiography.
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